Abstract
Herbacetin is a bioactive flavanol compound that has various pharmacological effects. However, the pharmacokinetic characteristics have not been thoroughly investigated. Previously, we screened a natural compound library and identified herbacetin as a potent CYP blocker. Herein, we aimed to mechanistically determine the inhibitory effects of herbacetin on CYP450 and its potential application. A human liver microsome incubation system was developed based on a UPLC-MS/MS method. Moreover, an in silico docking assay and a human CYP recombinase reaction system were developed and used to investigate binding affinity and inhibitory efficacy. Subsequently, the effects of the combination of herbacetin and sorafenib on HepG2 cells were assessed by MTT and immunoblotting assays. The concentration of sorafenib and its main metabolite were measured by UPLC-MS/MS after incubation with or without herbacetin. As a result, we found herbacetin almost completely inhibited the functions of major CYPs at 100 µM. Moreover, through analysis of the structure-activity relationship, we found 4-, 6-, and 8-hydroxyl were essential groups for the inhibitory effects. Herbacetin inhibited CYP3A4, CYP2B6, CYP2C9, and CYP2E1 in a mixed manner, but non-competi...Continue Reading
References
Jan 1, 2008·Drug Metabolism Letters·Loren M Berry, Zhiyang Zhao
Aug 13, 2010·Expert Opinion on Drug Metabolism & Toxicology·Shu-Ming HeShu-Feng Zhou
Nov 3, 2010·British Journal of Clinical Pharmacology·David G Bailey
Nov 6, 2010·BMC Bioinformatics·Fang BaiHonglin Li
Nov 9, 2010·Chemical Research in Toxicology·Tsutomu ShimadaMasayuki Komori
Apr 2, 2011·Current Drug Metabolism·Qi ChenDong-Qing Wei
Apr 20, 2012·Biochemical Pharmacology·Sussan GhassabianMichael Murray
May 2, 2012·BMC Bioinformatics·Emanuele BramucciStefano Pascarella
Aug 3, 2012·Planta medica·Robert Hermann, Oliver von Richter
Oct 16, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yan QiaoXuebo Liu
Oct 1, 2013·Acta Pharmacologica Sinica·Da-peng DaiJian-ping Cai
Nov 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·David M StresserKenneth Grime
Mar 13, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ophélie FliniauxChristophe Hano
Dec 4, 2014·Basic & Clinical Pharmacology & Toxicology·Da-Peng DaiJian-Ping Cai
Dec 10, 2014·Chemical Research in Toxicology·Tina B GillaniMichael Murray
Aug 25, 2015·European Journal of Pharmacology·Liang LiYunjo Soh
Nov 20, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Xianming WangJingfeng Liu
Dec 18, 2015·Cancer Research·Dong Joon KimZigang Dong
Feb 27, 2016·Drug Metabolism Reviews·Bing-Liang Ma, Yue-Ming Ma
Mar 1, 2017·Pharmacogenomics·Guo-Xin HuJian-Ping Cai
Jul 22, 2017·Pharmacogenetics and Genomics·Liang GongLan Fan
Nov 9, 2017·Basic & Clinical Pharmacology & Toxicology·Ren-Ai XuGuo-Xin Hu
Mar 25, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jingjing YuIsabelle Ragueneau-Majlessi
Aug 24, 2018·Toxicology Letters·Su-Su BaoGuo-Xin Hu
Oct 3, 2018·International Journal of Molecular Sciences·Jieqiang ZhuMinjun Chen
Nov 18, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jingjing YuIsabelle Ragueneau-Majlessi
Jan 11, 2019·The AAPS Journal·Sussan GhassabianMichael Murray
Apr 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maryam ForoozeshJiawang Liu
May 10, 2019·Pharmaceutical Biology·Gang DongXiaoli Song
Aug 28, 2019·Current Drug Metabolism·Jiajia LiGuangChun Sun
Nov 11, 2019·Toxicology Letters·Shyam H KambleBonnie A Avery
Nov 14, 2019·Current Topics in Medicinal Chemistry·S Suroowan, M F Mahomoodally
Nov 15, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Seri JoMi-Sun Kim